Tevogen Bio Holdings Inc. (TVGN) — Stock Valuation & Research

Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.

TVGN key statistics

Price$5.97
Market cap$24.86M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range3.636-32.5
Beta0.2

Explore TVGN's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.